Carter Bank and Trust (CARE)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NASDAQ
Market Cap: $644.16M
Last updated: Nov 17, 2026 at 11:04 AM ET
Carter Bank and Trust (CARE) Stock Forecast
Analysts expect Carter Bank and Trust (CARE) to earn $4.88 per share in the fiscal year ending Dec 31, 2026, on revenue of $258.30M. Of 4 analysts, 1 rates the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.75, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 25% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 25.0% |
| Hold | 3 | 75.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 48.6% and revenue estimates fall 21.9%.
- Fiscal year ending Dec 31, 2026
- $4.88
- EPS consensus, revenue $258.30M
- Fiscal year ending Dec 31, 2027
- $2.51
- EPS consensus, revenue $201.74M
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.88 | $4.06 to $5.35 | 3 | $258.30M | $246.70M to $269.90M | 2 |
| Dec 31, 2027 | $2.51 | $2.45 to $2.57 | 4 | $201.74M | $201.40M to $202.07M | 2 |
Quarterly Estimates
The EPS consensus falls from $0.58 for the quarter ending Dec 31, 2026 to $0.57 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.58 | $0.54 to $0.63 | 6 | $49.66M | $47.30M to $51.55M | 4 |
| Mar 31, 2027 | $0.57 | $0.55 to $0.60 | 4 | $46.57M | $43.30M to $48.21M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 11.3% from $5.50.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.88 | $5.76 | $5.76 | $5.76 | $5.50 | -11.3% |
| Fiscal year ending Dec 31, 2027 | $2.51 | $2.60 | $2.60 | $2.60 | $2.58 | -2.7% |
| Quarter ending Mar 31, 2027 | $0.57 | $0.59 | $0.59 | $0.59 | $0.59 | -3.0% |
Frequently Asked Questions About CARE
What is the CARE stock forecast?
Consensus analyst estimates put Carter Bank and Trust's EPS at $4.88 for the fiscal year ending Dec 31, 2026, on revenue of $258.30M. The consensus rating from 4 analysts is Hold.
How do analysts rate CARE stock?
Of 4 analysts covering Carter Bank and Trust, 0 rate it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CARE next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.88, with estimates from $4.06 to $5.35 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.51, with estimates from $2.45 to $2.57 from 4 analysts.
What revenue do analysts expect from Carter Bank and Trust next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $258.30M, with estimates from $246.70M to $269.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $201.74M, with estimates from $201.40M to $202.07M.
How many analysts cover CARE?
4 analysts rate Carter Bank and Trust stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CARE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors